HDAC9 and cancer: Reduction of the platinum (IV) divalproate (VAAP) complex generates cisplatin and 2 equivalents of valproic acid, a potent histone deacetylase (HDAC) inhibitor that stimulates differentiation and apoptosis in cancer cells [88].